In Silico Approach for the Evaluation of the Potential Antiviral Activity of Extra Virgin Olive Oil (EVOO) Bioactive Constituents Oleuropein and Oleocanthal on Spike Therapeutic Drug Target of SARS-CoV-2
Since there is an urgent need for novel treatments to combat the current coronavirus disease 2019 (COVID-19) pandemic, in silico molecular docking studies were implemented as an attempt to explore the ability of selected bioactive constituents of extra virgin olive oil (EVOO) to act as potent SARS-C...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-11-01
|
| Series: | Molecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1420-3049/27/21/7572 |
| _version_ | 1797467042588131328 |
|---|---|
| author | Elena G. Geromichalou George D. Geromichalos |
| author_facet | Elena G. Geromichalou George D. Geromichalos |
| author_sort | Elena G. Geromichalou |
| collection | DOAJ |
| description | Since there is an urgent need for novel treatments to combat the current coronavirus disease 2019 (COVID-19) pandemic, in silico molecular docking studies were implemented as an attempt to explore the ability of selected bioactive constituents of extra virgin olive oil (EVOO) to act as potent SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) antiviral compounds, aiming to explore their ability to interact with SARS-CoV-2 Spike key therapeutic target protein. Our results suggest that EVOO constituents display substantial capacity for binding and interfering with Spike (S) protein, both wild-type and mutant, via the receptor-binding domain (RBD) of Spike, or other binding targets such as angiotensin-converting enzyme 2 (ACE2) or the RBD-ACE2 protein complex, inhibiting the interaction of the virus with host cells. This in silico study provides useful insights for the understanding of the mechanism of action of the studied compounds at a molecular level. From the present study, it could be suggested that the studied active phytochemicals could potentially inhibit the Spike protein, contributing thus to the understanding of the role that they can play in future drug designing and the development of anti-COVID-19 therapeutics. |
| first_indexed | 2024-03-09T18:48:02Z |
| format | Article |
| id | doaj.art-7d8d72c4e4544f929ecc2d96c5fc912a |
| institution | Directory Open Access Journal |
| issn | 1420-3049 |
| language | English |
| last_indexed | 2024-03-09T18:48:02Z |
| publishDate | 2022-11-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Molecules |
| spelling | doaj.art-7d8d72c4e4544f929ecc2d96c5fc912a2023-11-24T06:06:27ZengMDPI AGMolecules1420-30492022-11-012721757210.3390/molecules27217572In Silico Approach for the Evaluation of the Potential Antiviral Activity of Extra Virgin Olive Oil (EVOO) Bioactive Constituents Oleuropein and Oleocanthal on Spike Therapeutic Drug Target of SARS-CoV-2Elena G. Geromichalou0George D. Geromichalos1Laboratory of Pharmacology, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias Street, 11527 Athens, GreeceDepartment of General and Inorganic Chemistry, Faculty of Chemistry, Aristotle University of Thessaloniki, 54124 Thessaloniki, GreeceSince there is an urgent need for novel treatments to combat the current coronavirus disease 2019 (COVID-19) pandemic, in silico molecular docking studies were implemented as an attempt to explore the ability of selected bioactive constituents of extra virgin olive oil (EVOO) to act as potent SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) antiviral compounds, aiming to explore their ability to interact with SARS-CoV-2 Spike key therapeutic target protein. Our results suggest that EVOO constituents display substantial capacity for binding and interfering with Spike (S) protein, both wild-type and mutant, via the receptor-binding domain (RBD) of Spike, or other binding targets such as angiotensin-converting enzyme 2 (ACE2) or the RBD-ACE2 protein complex, inhibiting the interaction of the virus with host cells. This in silico study provides useful insights for the understanding of the mechanism of action of the studied compounds at a molecular level. From the present study, it could be suggested that the studied active phytochemicals could potentially inhibit the Spike protein, contributing thus to the understanding of the role that they can play in future drug designing and the development of anti-COVID-19 therapeutics.https://www.mdpi.com/1420-3049/27/21/7572extra virgin olive oil (EVOO) constituentsmolecular dockingSARS-CoV-2 Spike proteinSARS-CoV-2 mutation variantsomicron-delta-alpha-beta-gamma-epsilon-kappa |
| spellingShingle | Elena G. Geromichalou George D. Geromichalos In Silico Approach for the Evaluation of the Potential Antiviral Activity of Extra Virgin Olive Oil (EVOO) Bioactive Constituents Oleuropein and Oleocanthal on Spike Therapeutic Drug Target of SARS-CoV-2 Molecules extra virgin olive oil (EVOO) constituents molecular docking SARS-CoV-2 Spike protein SARS-CoV-2 mutation variants omicron-delta-alpha-beta-gamma-epsilon-kappa |
| title | In Silico Approach for the Evaluation of the Potential Antiviral Activity of Extra Virgin Olive Oil (EVOO) Bioactive Constituents Oleuropein and Oleocanthal on Spike Therapeutic Drug Target of SARS-CoV-2 |
| title_full | In Silico Approach for the Evaluation of the Potential Antiviral Activity of Extra Virgin Olive Oil (EVOO) Bioactive Constituents Oleuropein and Oleocanthal on Spike Therapeutic Drug Target of SARS-CoV-2 |
| title_fullStr | In Silico Approach for the Evaluation of the Potential Antiviral Activity of Extra Virgin Olive Oil (EVOO) Bioactive Constituents Oleuropein and Oleocanthal on Spike Therapeutic Drug Target of SARS-CoV-2 |
| title_full_unstemmed | In Silico Approach for the Evaluation of the Potential Antiviral Activity of Extra Virgin Olive Oil (EVOO) Bioactive Constituents Oleuropein and Oleocanthal on Spike Therapeutic Drug Target of SARS-CoV-2 |
| title_short | In Silico Approach for the Evaluation of the Potential Antiviral Activity of Extra Virgin Olive Oil (EVOO) Bioactive Constituents Oleuropein and Oleocanthal on Spike Therapeutic Drug Target of SARS-CoV-2 |
| title_sort | in silico approach for the evaluation of the potential antiviral activity of extra virgin olive oil evoo bioactive constituents oleuropein and oleocanthal on spike therapeutic drug target of sars cov 2 |
| topic | extra virgin olive oil (EVOO) constituents molecular docking SARS-CoV-2 Spike protein SARS-CoV-2 mutation variants omicron-delta-alpha-beta-gamma-epsilon-kappa |
| url | https://www.mdpi.com/1420-3049/27/21/7572 |
| work_keys_str_mv | AT elenaggeromichalou insilicoapproachfortheevaluationofthepotentialantiviralactivityofextravirginoliveoilevoobioactiveconstituentsoleuropeinandoleocanthalonspiketherapeuticdrugtargetofsarscov2 AT georgedgeromichalos insilicoapproachfortheevaluationofthepotentialantiviralactivityofextravirginoliveoilevoobioactiveconstituentsoleuropeinandoleocanthalonspiketherapeuticdrugtargetofsarscov2 |